Merck Donates $500,000 to Support River Blindness and Lymphatic Filariasis Elimination Efforts


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ Merck Donates $500,000 to Support River Blindness and Lymphatic Filariasis Elimination Efforts
Merck and the MECTIZAN Donation Program, announced today a $500,000 cash donation to support NGO partners working to eliminate onchocerciasis and lymphatic filariasis

Merck, known as MSD outside the United States and Canada, and the MECTIZAN Donation Program (MDP), announced today a $500,000 cash donation to support non-governmental organization (NGO) partners working to eliminate river blindness (onchocerciasis) and lymphatic filariasis (LF). The funds are being provided by Merck and will be administered through an application process managed by the MDP, a public-private partnership that oversees elimination efforts of these two diseases. This funding will be offered in the form of grants to support the implementation of the World Health Organization’s (WHO’s) recommended precautionary measures to decrease the risk of the spread of SARS-CoV-2 during mass drug administration (MDA).

In April, in response to the pandemic, WHO issued interim guidance to countries to suspend community interventions targeting the elimination of neglected tropical diseases, including MDA. After months of careful assessment, in July, WHO released a decision-making framework for resuming MDA during the ongoing pandemic. The framework is based on a two-step approach: a risk–benefit assessment to decide if the planned activity should proceed; and, if activities move forward, a list of precautionary measures that should be applied to help decrease the risk of transmission of SARS-CoV-2 and strengthen the capacity of the health system to manage any residual risk. These important precautionary measures will result in an increase in program costs, which may be a burden to some countries and their implementing partners.

“The SARS-CoV-2 pandemic is especially challenging for communities that continue to be threatened by river blindness and lymphatic filariasis. We can’t lose momentum and must strengthen our global partnerships to eliminate these infections,” said Dr. Julie L. Gerberding, chief patient officer at Merck. “We hope these grants will help sustain the implementation of good public health measures and protect people’s safety as they fight against these preventable diseases during this especially difficult time.”

Dr. Yao Sodahlon, MDP Director, stated "As the global community continues to battle the SARS-CoV-2 pandemic, we remain committed to the health of our staff, the health of our partners, and the health of endemic communities. This grant opportunity will facilitate the implementation of robust safety measures when mass drug administration with MECTIZAN resumes.”

Through the MDP and its partners -- including the ministries of health in endemic countries, impacted communities, NGOs, WHO, and donors -- more than 300 million people are reached each year. Since the inception of the program in 1987, Merck has donated more than 4 billion treatments.

Tags : #LatestPhramaNewsOct22 #LatestMerckNewsOct22 #Onchocerciasis #RiverBlindness #LymphaticFilariasis

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

University of Birmingham Dubai invites applications for MSc in Financial Data ScienceJuly 08, 2025
Benefits of ShirodharaJuly 07, 2025
WIKA India Launches “Re-Inventing Hygiene” Campaign to Advance Standards in Food & Pharma InstrumentationJuly 07, 2025
Cambodia is 2nd Asian country to rollout long-acting injectable HIV prevention optionJuly 07, 2025
Wheels of Care: How Tele-MRVs Are Reaching Mothers Left BehindJuly 07, 2025
Personalized Psychiatry's Developing Use of PharmacogenomicsJuly 07, 2025
Honourable Ministers Shri Anil Kumar Bachoo and Shri Palanivel Thiaga Rajan Open IIRSI 2025 Convention on Intraocular Implant & Refractive SurgeryJuly 05, 2025
A 69-year-old retired teacher gives a lesson of life by donating multiple organsJuly 05, 2025
Silent Scans, Smarter Eyes: Inside India’s First AI Teleradiology HubsJuly 05, 2025
Can You Hear Me Now? The Quiet Revolution of Tele-Audiology in Rural Childhood CareJuly 05, 2025
What’s on Their Plate? Uncovering Malnutrition Through Midday Meal DataJuly 05, 2025
Can Diabetics Conquer Space? The Mission That’s Changing Medicine on Earth and BeyondJuly 05, 2025
Center for Diagnostics and Telemedicine Celebrates Graduation of First Masters in Medical Artificial IntelligenceJuly 04, 2025
Sightsavers India Fellowship Programme Invites Applications for 2025July 04, 2025
After 4 Surgeries & 15kg Abdominal Tumour, 61-YO Reclaims Life In Marathon Operation At HCGMCCJuly 04, 2025
The DNA Warning: Are Genomic Screening Camps the Early Alarm We Need?July 04, 2025
Ticked, Tapped, and Forgotten? The Truth About Digital Consent FormsJuly 04, 2025
Evaluating the Impact of AI Chatbots in Mental Health Support for College StudentsJuly 04, 2025
Integrating Oral Health with Primary Care: Pilot Programs in Rural MaharashtraJuly 04, 2025
Will governments firewall public health from tobacco industry's lies and deceptive tactics?July 03, 2025